Bellwether technology is an emerging company with a mission to bring personalized medicine to the masses by combining the power of big data, genetics, and genomics. The company focuses on three core technologies – genetics, big data analytics, and artificial intelligence.
Genetics
The company’s genetics solution is the world’s first DNA-based, predictive disease risk score tool for consumers, healthcare providers, and pharmaceutical companies. It predicts a person’s probability of developing specific diseases, helping them to make better decisions and to take right preventive actions. The company’s platform has been validated in several randomized clinical trials and is the first to provide direct access to DNA test results for all US-based customers.
Big Data Analytics
The company uses big data analytics to analyze a person’s DNA to predict disease risks and treatment responses. Its platform analyzes the entire genome, including the non-coding and regulatory regions, and incorporates all of a person’s data, such as medical records and genetic and environmental factors.
Artificial Intelligence
The company’s AI technology analyzes the human genome and other big data to predict a person’s disease risks and treatments, using machine learning algorithms to develop a personalized model based on thousands of variables. Its AI algorithm compares a patient’s genomic information to millions of patients and learns what is typical for that individual. The company’s artificial intelligence (AI) software has outperformed doctors in diagnosing various diseases, including breast cancer, prostate cancer, colorectal cancer, and Parkinson’s disease.
Conclusion:
The company is committed to providing a personalized medicine experience that is accessible, affordable, and efficient. It is currently developing a consumer health app for consumers and healthcare professionals to use to make better decisions.
